Corporate Breaking News
Corporate Breaking News
Home : argenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE® Technology
Feb 04
2019

argenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE® Technology

BREDA, the Netherlands and GHENT, Belgium and SAN DIEGO, Feb. 4, 2019 /PRNewswire/ -- argenx (Euronext & Nasdaq: ARGX) and Halozyme Therapeutics, Inc. (Nasdaq: HALO) today announced a global collaboration and license agreement that enables use by argenx of Halozyme's ENHANZE® drug...
Source:https://www.prnewswire.com:443/news-releases/argenx-and-halozyme-enter-global-collaboration-and-license-agreement-for-enhanze-technology-300788746.html
 
Related News
» SaaS Company Syrenis Attracts Investment From Bill Currie and Sir Terry Leahy
» Veteran detective killed, partner wounded in shooting; 'suicidal' suspect in custody
Home
About us
Archive
Sitemap
Powered By Corporate Breaking News.com Home| About us| Archive News| Sitemap